Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
US10894804B2 · kind B2 · utility
2Cited by
135References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2020 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | Jul 1, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.